Complications of Cardiac Transplantation
- 10 July 2018
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 20 (9) , 1-11
Abstract
Purpose of Review Despite the improvement in medical therapy for heart failure and the advancements in mechanical circulatory support, heart transplantation (HT) still remains the best therapeutic option to improve survival and quality of life in patients with advanced heart failure. Nevertheless, HT recipients are exposed to the risk of several potential complications that may impair their outcomes. In this article, we aim to provide a practical and scholarly framework for clinicians approaching heart transplant medicine, as well as a concise update for the experienced readers on the most relevant post-HT complications. Recent Findings While recognizing that most of the treatments herein discussed are based more on experience than on solid scientific evidence, significant step forward has been made in particular in the recognition and management of primary graft dysfunction, antibody-mediated rejection, and renal dysfunction. Summary Complications after HT may vary according to the time from surgery and can be related to graft function and pathology or to diseases and dysfunctions occurring in other organs or systems, mainly as side effects of immunosuppressive drugs and progression of pre-existing conditions. Future research needs to focus on improving precision diagnostics of causes of graft dysfunction and on reaching an optimal and customized balance between efficacy and toxicities of immunosuppressive strategies.Keywords
This publication has 79 references indexed in Scilit:
- Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ TransplantationTransplantation, 2013
- Mechanical circulatory support after heart transplantationEuropean Journal of Cardio-Thoracic Surgery, 2011
- Lung Cancer after Heart Transplantation: Results from a Large Multicenter RegistryAmerican Journal of Transplantation, 2011
- Primary Graft Failure After Heart Transplantation: The Importance of Donor Pharmacological ManagementTransplantation Proceedings, 2010
- Minimization of immunosuppressionTransplant Immunology, 2008
- Cytomegalovirus-associated allograft rejection in heart transplant patientsCurrent Opinion in Infectious Diseases, 2007
- Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral ProphylaxisJournal of Clinical Microbiology, 2007
- Immunosuppressive Therapy and Malignancy in Organ Transplant RecipientsDrugs, 2007
- Primer: histopathology of calcineurin-inhibitor toxicity in renal allograftsNature Clinical Practice Nephrology, 2006
- Prophylaxis for CMV should not now replace pre‐emptive therapy in solid organ transplantationReviews in Medical Virology, 2001